Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
4BIO Capital logo

4BIO Capital

Europe, England, United Kingdom, London

Description

4BIO Capital is a specialist fund focused on investing in and building early stage advanced therapy companies

Investor Profile

4BIO Capital has backed more than 17 startups, with 1 new investments in the last 12 months alone. The firm has led 7 rounds, about 41% of its total and boasts 6 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (53%)
  • Series B (24%)
  • Series C (12%)
  • Seed (12%)

Country Focus

  • United States (47%)
  • United Kingdom (18%)
  • Switzerland (18%)
  • France (12%)
  • Japan (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Therapeutics
  • Biopharma
  • Pharmaceutical
  • Genetics
  • Health Diagnostics
  • Consulting
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 4BIO Capital frequently co-invest with?

Solasta Ventures
Solasta Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Agent Capital
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
UPMC Enterprises
UPMC Enterprises
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 4
MRL Ventures Fund
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
TPG Biotech
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 2
HealthCap
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
SL
SymBiosis LLC
North America, District of Columbia, United States, Washington
Co-Investments: 2
Takeda Ventures
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 3
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Asia, Guangdong, China, Zhuhai
Co-Investments: 2
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2

What are some of recent deals done by 4BIO Capital?

Trogenix

Edinburgh, Edinburgh, City of, United Kingdom

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series AOct 6, 2025
Amount Raised: $94,104,615
Actithera

Oslo, Oslo, Norway

Actithera is a molecular radiotherapeutic company that develops radioligand therapies.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series AJul 9, 2025
Amount Raised: $75,500,000
March Biosciences

Houston, Texas, United States

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series AOct 23, 2024
Amount Raised: $28,400,000
ViaNautis

Cambridge, Cambridgeshire, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

BiopharmaBiotechnologyMedical
Series ANov 13, 2023
Amount Raised: $24,558,590
Ray Therapeutics

San Diego, California, United States

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

BiotechnologyHealth CareTherapeutics
Series AMay 16, 2023
Amount Raised: $100,000,000
Ascend Gene & Cell Therapies

Potters Bar, Hertford, United Kingdom

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

BiotechnologyConsultingManufacturingTherapeutics
Series AMay 9, 2023
Amount Raised: $65,900,000
Entact Bio

Watertown, Massachusetts, United States

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

BiopharmaBiotechnologyLife ScienceMedical
Series ADec 6, 2022
Amount Raised: $81,000,000
Araris Biotech

Zürich, Zurich, Switzerland

Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.

BiotechnologyHealth Care
Series AOct 4, 2022
Amount Raised: $24,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
SparingVision

Paris, Ile-de-France, France

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

BiotechnologyHealth CareLife Science
Series BSep 14, 2022
Amount Raised: $74,864,346

Find More Investors Like 4BIO Capital

Discover similar investors in our database and build your perfect investor list.

series_a InvestorsInvestors in LondonBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors